ADCT (STOCKS)
ADC Therapeutics SA
$3.810000
+0.070000 (+1.87%)
Prev close: $3.740000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ameet Mallik
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $485.31M
- Employees
- 263
- P/E (TTM)
- -3.11
- P/B (TTM)
- -2.53
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $81.36M |
| Benefits Costs and Expenses | $222.97M |
| Cost Of Revenue | $5.80M |
| Costs And Expenses | $202.86M |
| Gross Profit | $75.56M |
| Nonoperating Income/Loss | -$20.11M |
| Operating Expenses | $197.06M |
| Research and Development | $104.01M |
| Other Operating Expenses | $93.05M |
| Operating Income/Loss | -$121.50M |
| Income/Loss Before Equity Method Investments | -$141.61M |
| Income/Loss From Continuing Operations After Tax | -$142.62M |
| Income/Loss From Continuing Operations Before Tax | -$141.61M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | $1.02M |
| Income Tax Expense/Benefit, Current | $1.02M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$142.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$142.62M |
| Net Income/Loss Available To Common Stockholders, Basic | -$142.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.12 |
| Diluted Earnings Per Share | -$1.12 |
| Basic Average Shares | 127,067,540 |
| Diluted Average Shares | 127,067,540 |
| Assets | $323.15M |
| Current Assets | $306.34M |
| Inventory | $4.18M |
| Other Current Assets | $302.15M |
| Noncurrent Assets | $16.82M |
| Fixed Assets | $0.00 |
| Liabilities | $508.98M |
| Current Liabilities | $70.16M |
| Accounts Payable | $9.18M |
| Other Current Liabilities | $60.99M |
| Noncurrent Liabilities | $438.82M |
| Equity | -$185.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$185.83M |
| Liabilities And Equity | $323.15M |
| Net Cash Flow From Operating Activities | -$141.17M |
| Net Cash Flow From Operating Activities, Continuing | -$141.17M |
| Net Cash Flow From Investing Activities | $395.00K |
| Net Cash Flow From Investing Activities, Continuing | $395.00K |
| Net Cash Flow From Financing Activities | $150.95M |
| Net Cash Flow From Financing Activities, Continuing | $150.95M |
| Exchange Gains/Losses | $305.00K |
| Net Cash Flow | $10.47M |
| Net Cash Flow, Continuing | $10.17M |
| Comprehensive Income/Loss | -$141.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$141.72M |
| Other Comprehensive Income/Loss | -$141.72M |
| Other Comprehensive Income/Loss Attributable To Parent | $904.00K |